These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11933747)
21. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model. Gordon YJ; Romanowski EG; Araullo-Cruz T Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711 [TBL] [Abstract][Full Text] [Related]
22. [Extensive oral condylomas treated by in situ cidofovir injection in an HIV patient]. Beaulieu D; Burnouf M; Plantier F; Régnier S; Lacau Saint-Guily J; Avril MF; Dupin N Ann Dermatol Venereol; 2008 Apr; 135(4):307-11. PubMed ID: 18420080 [TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Johnson JA; Gangemi JD Antimicrob Agents Chemother; 1999 May; 43(5):1198-205. PubMed ID: 10223936 [TBL] [Abstract][Full Text] [Related]
24. Cidofovir and surgery for genital warts. TreatmentUpdate; 2002 Feb; 14(2):3-4. PubMed ID: 12691039 [No Abstract] [Full Text] [Related]
25. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox. Toro JR; Sanchez S; Turiansky G; Blauvelt A Dermatol Clin; 2003 Apr; 21(2):301-9. PubMed ID: 12757253 [TBL] [Abstract][Full Text] [Related]
26. Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. Calista D J Eur Acad Dermatol Venereol; 2000 Nov; 14(6):484-8. PubMed ID: 11444271 [TBL] [Abstract][Full Text] [Related]
27. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir. Calista D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816 [TBL] [Abstract][Full Text] [Related]
28. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy. Davis MD; Gostout BS; McGovern RM; Persing DH; Schut RL; Pittelkow MR J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):340-3. PubMed ID: 10901717 [TBL] [Abstract][Full Text] [Related]
29. Treatment of verruca vulgaris with topical cidofovir. Zabawski EJ; Sands B; Goetz D; Naylor M; Cockerell CJ JAMA; 1997 Oct; 278(15):1236. PubMed ID: 9333263 [No Abstract] [Full Text] [Related]
30. 1% topical cidofovir used as last alternative to treat viral infections. Briand S; Milpied B; Navas D; Thomare P; Stalder JF J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):249-50. PubMed ID: 18211429 [No Abstract] [Full Text] [Related]
31. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. Hou J; Major EO J Neurovirol; 1998 Aug; 4(4):451-6. PubMed ID: 9718138 [TBL] [Abstract][Full Text] [Related]
32. Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment. Di Lucca-Christment J; Jacobelli S; Gressier L; Plantier F; Laude H; Rozenberg F; Morini JP; Dallot A; Avril MF; Dupin N AIDS; 2012 Feb; 26(4):523-6. PubMed ID: 22210631 [TBL] [Abstract][Full Text] [Related]
33. Topical cidofovir for erythroplasia of Queyrat of the glans penis. Calista D Br J Dermatol; 2002 Aug; 147(2):399-400. PubMed ID: 12174131 [No Abstract] [Full Text] [Related]
36. Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata. Coremans G; Margaritis V; Snoeck R; Wyndaele J; De Clercq E; Geboes K Dis Colon Rectum; 2003 Aug; 46(8):1103-8; discussion 1108-9. PubMed ID: 12907906 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. Van Cutsem E; Snoeck R; Van Ranst M; Fiten P; Opdenakker G; Geboes K; Janssens J; Rutgeerts P; Vantrappen G; de Clercq E J Med Virol; 1995 Feb; 45(2):230-5. PubMed ID: 7775945 [TBL] [Abstract][Full Text] [Related]
38. NDA filed to treat refractory herpes. AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756 [No Abstract] [Full Text] [Related]
39. [Treatment of anogenital warts with topical cidofovir]. Fernández-Morano T; Del Boz J; Frieyro-Elichegui M; Repiso JB; Padilla-España L; de Troya-Martín M Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):222-6. PubMed ID: 23182242 [TBL] [Abstract][Full Text] [Related]
40. Gilead announces phase I/II data insufficient for marketing clearance of FORVADE topical gel to treat refractory herpes in patients with AIDS. AIDS Patient Care STDS; 1997 Aug; 11(4):293. PubMed ID: 11361852 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]